Articles > Business magazines > Specialty and Local Interest magazines > Business North Carolina articles > October 1999

Article: Medicine man's vision is to get Glaxo on warpath.(Pres. and CEO George Morrow's growth strategy for Glaxo Wellcome Inc.)

Article from:
Business North Carolina
Article date:
October 1, 1999
Copyright

As a young drug salesman for Merck & Co. Inc. 18 years ago, George Morrow called on a Manhattan doctor and presented his business card, which described him as an "antibiotics specialist."

"What makes you an antibiotics specialist?" the doctor barked.

"I didn't have a comeback," Morrow recalls. "So I came clean and said, 'Because it is on my card.'"

The doctor laughed and wound up prescribing Merck antibiotics. Now Morrow, 47, faces a more difficult sales job: convincing investors and customers that he has the right prescription for Research Triangle Park-based Glaxo Wellcome Inc. Morrow became president and CEO of the company after his ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Glaxo Wellcome, NeXstar Pharmaceuticals Sign ...
PR Newswire;  May 27, 1998 ;     700+ words ... ... Pharmaceuticals, Inc. (Nasdaq: NXTR) and Glaxo Wellcome (London: GLXO) announced today a ... collaboration, including a license by Glaxo Wellcome for the use of NeXstar Pharmaceuticals ... research tool for target validation in Glaxo Wellcome's functional genomics programs ...

Article: Glaxo Wellcome Signs $1.3M Deal with Domain ...
Business Wire;  January 19, 1999 ;     700+ words ... ... HealthWire)--Jan. 19, 1999-- Glaxo Wellcome hopes to gain unique competitive advantage ... company has signed an agreement with Glaxo Wellcome, Inc., a leading research-based ... Starfire(TM) Groupware system to Glaxo Wellcome development and manufacturing sites ...

Article: PowderJect & Glaxo Wellcome Sign DNA Vaccine ...
PR Newswire;  March 4, 1998 ;     700+ words ... ... plc (London: PJP) (PowderJect) and Glaxo Wellcome plc (London: GLXO) (Glaxo Wellcome) today announced that the two companies ... license and option agreement granting Glaxo Wellcome exclusive, worldwide rights to develop ...

Article: CuraGen and Glaxo Wellcome Initiate ...
PR Newswire;  November 20, 1998 ;     700+ words ... ... Technologies to Accelerate Evaluation of Glaxo Wellcome Preclinical Drug Pipeline NEW HAVEN ... CuraGen Corporation (Nasdaq: CRGN) and Glaxo Wellcome Inc. (NYSE: GLX) announced today ... processes for the study and selection of Glaxo Wellcome compounds for clinical development ...

Article: VERTEX AND GLAXO WELLCOME OBTAIN LICENSE TO G.D. ...
PR Newswire;  July 1, 1996 ;     700+ words ... ... Incorporated (Nasdaq: VRTX) and Glaxo Wellcome plc (NYSE: GLX) announced today ... The companies also announced that Glaxo Wellcome has made a $5 million equity investment ... Vertex. With the license, Vertex and Glaxo Wellcome can continue to develop, manufacture ...

Article: Catalytica To Buy Glaxo Wellcome Pharmaceutical ...
PR Newswire;  February 5, 1997 ;     700+ words ...Company To Produce Medicines For Glaxo Wellcome; Minimal Impact Seen In Employment ... C., Feb. 5 /PRNewswire/ -- Glaxo Wellcome Inc. and Catalytica Inc. (Nasdaq ... of intent for Catalytica to acquire Glaxo Wellcome's pharmaceutical production facility ...

Article: Proposed Merger of Glaxo Wellcome and SmithKline ...
PR Newswire;  January 17, 2000 ;     700+ words ... ... conditions or undertakings of Glaxo Wellcome or SmithKline Beecham that are not satisfactory to both Glaxo Wellcome and SmithKline Beecham and, in ... receipt in a form satisfactory to Glaxo Wellcome and SmithKline Beecham of confirmation ...

Article: Glaxo Wellcome and SmithKline Beecham Merger ...
PR Newswire;  December 18, 2000 ;     700+ words ... ... PHILADELPHIA, Dec. 18 /PRNewswire/ -- Glaxo Wellcome (NYSE: GLX) and SmithKline Beecham ... their merger to form GlaxoSmithKline. Glaxo Wellcome and SmithKline Beecham have now obtained ... following completion of the merger. Glaxo Wellcome and SmithKline Beecham continue to ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives